A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/202 (2006.01) A23L 1/30 (2006.01) A61K 47/12 (2006.01) A61K 47/14 (2006.01) A61K 47/24 (2006.01) A61P 9/02 (2006.01) A61P 9/10 (2006.01) A61P 25/16 (2006.01) A61P 25/28 (2006.01) A61P 27/12 (2006.01)
Patent
CA 2632949
The present invention relates to the use of an acid enriched in docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) or DHA-derived EPA for manufacturing a drug for the treatment of processes that involve associated oxidative damage. In particular, it is for the treatment of processes associated with neurodegenerative, ocular, ischaemic and inflammatory pathology, atherosclerosis, with oxidative damage to DNA and with physical exercise.
La présente invention concerne l'utilisation d'un acide enrichi en acide docosahexaénoïque (DHA) ou en acide éicosapentaénoïque (EPA) ou en EPA dérivé de DHA pour fabriquer un médicament pour le traitement de processus qui mettent en AEuvre un dommage oxydatif associé. En particulier, elle est destinée au traitement de processus associés à une pathologie neurodégénérative, oculaire, ischémique et inflammatoire, l'athérosclérose, avec un dommage oxydatif de l'ADN et avec l'exercice physique.
Domingo Pedrol Joan Carles
Villegas Garcia Jose Antonio
Brudy Technology S.l.
Robic
LandOfFree
Use of dha, epa or dha-derived epa for treating a pathology... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of dha, epa or dha-derived epa for treating a pathology..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of dha, epa or dha-derived epa for treating a pathology... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1582109